PSNC resists proposed Category D changes

摘要

The Pharmaceutical Services Negotiating Committee is to try to resist changes to the Category D Drug Tariff classification of medicines that are in short supply. At a press briefing on October 4 following the committee's September meeting, Mr Wally Dove (chairman, PSNC) said that the Department of Health had proposed draconia changes to the system.